{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:19:43Z","timestamp":1785161983662,"version":"3.55.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.neuropharm.2011.07.016","type":"journal-article","created":{"date-parts":[[2011,8,4]],"date-time":"2011-08-04T01:37:46Z","timestamp":1312421866000},"page":"256-263","source":"Crossref","is-referenced-by-count":13,"title":["Interactions between corticotropin-releasing factor and the serotonin 1A receptor system on acoustic startle amplitude and prepulse inhibition of the startle response in two rat strains"],"prefix":"10.1016","volume":"62","author":[{"given":"Lisa H.","family":"Conti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2011.07.016_bib1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1176\/ajp.156.4.585","article-title":"Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder","volume":"156","author":"Baker","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib2","doi-asserted-by":"crossref","unstructured":"Bakshi, VP., Alsene, KM., Roseboom, PH., Connors, EE. (in press) Enduring sensorimotor gating abnormalities following predator exposure or corticotropin-releasing factor in rats: a model for PTSD-like information-processing deficits?. Neuropharmacol.","DOI":"10.1016\/j.neuropharm.2011.01.040"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib3","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/74263","article-title":"Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behavior and are hypersensitive to stress","volume":"24","author":"Bale","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1146\/annurev.pharmtox.44.101802.121410","article-title":"CRF and CRF receptors: role in stress responsivity and other behaviors","volume":"44","author":"Bale","year":"2004","journal-title":"Ann. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib5","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A\u00a0review of central serotonin receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neuroscience.2010.11.026","article-title":"Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex","volume":"173","author":"Bijlsma","year":"2011","journal-title":"Neurosci"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s002130100810","article-title":"Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies","volume":"156","author":"Braff","year":"2001","journal-title":"Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib8","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1176\/ajp.154.5.624","article-title":"Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder","volume":"154","author":"Bremner","year":"1997","journal-title":"Am. J. Psychiat"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib9","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/sj.npp.1300282","article-title":"Stress sensitization of ethanol withdrawal-induced reduction in social interaction: inhibition by CRF-1 and a benzodiazepine receptor antagonists and a \u2013HT1A-receptor agonist","volume":"29","author":"Breese","year":"2004","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0006-8993(86)90539-1","article-title":"Corticotropin releasing factor (CRF) receptor antagonist blocks activating and \u2019anxiogenic\u2019 actions of CRF in the rat","volume":"369","author":"Britton","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib11","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.neuropharm.2006.11.004","article-title":"The opposite effect of a low and a high dose of serotonin-1A agonist on behavior induced by MK-801","volume":"52","author":"Bubenikova-Valesove","year":"2007","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib12","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/0896-6273(93)90230-O","article-title":"Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain","volume":"11","author":"Chang","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(98)01158-5","article-title":"Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1","volume":"835","author":"Contarino","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejphar.2004.11.055","article-title":"Characterization of the effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in Brown Norway and Wistar-Kyoto rats","volume":"507","author":"Conti","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s00213-002-1025-2","article-title":"Effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in two rat strains","volume":"161","author":"Conti","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib16","first-page":"837","article-title":"Serotonin receptor subtype agonists. Differential effects on sensorimotor reactivity measured with acoustic startle","volume":"22","author":"Davis","year":"1986","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.euroneuro.2004.01.004","article-title":"5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and Fluoxetine in the rat","volume":"14","author":"De Vry","year":"2004","journal-title":"Eur. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib18","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0006-3223(01)01323-3","article-title":"Reduced startle reactivity and plasticity in transgenic mice overexpressing corticotropin-releasing hormone","volume":"51","author":"Dirks","year":"2002","journal-title":"Biol. Psychiat"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0166-4328(00)00326-0","article-title":"5-HT1B receptor knockout, but not 5-HT1A receptor knockout mice, show reduced startle reactivity and footshock-induced sensitization, as measured with the acoustic startle response","volume":"118","author":"Dirks","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib20","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/S0028-3908(00)00030-7","article-title":"Effects of strain and serotonergic agents on prepulse inhibition and habituation in mice","volume":"39","author":"Dulawa","year":"2000","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib21","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0893-133X(99)00164-5","article-title":"Knockout mice reveal opposite roles for serotonin 1A and 1B receptors in prepulse inhibition","volume":"22","author":"Dulawa","year":"2000","journal-title":"Neuropsychopharm"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0165-0173(90)90012-D","article-title":"Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?","volume":"15","author":"Dunn","year":"1990","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0018-506X(87)90044-4","article-title":"Corticotropin-releasing factor has an anxiogenic action in the social interaction test","volume":"21","author":"Dunn","year":"1987","journal-title":"Horm. Beh"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib24","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1124\/jpet.109.162123","article-title":"Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors","volume":"333","author":"Gogos","year":"2010","journal-title":"J.\u00a0Pharmacol. Exper. Ther."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib25","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/sj.bjp.0707148","article-title":"The importance of baseline in identifying 8-OH-DPAT-induced effects on prepulse inhibition in rats","volume":"150","author":"Gogos","year":"2007","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1749-6632.1993.tb49922.x","article-title":"Amygdaloid CRF pathways. Role in autonomic, neuroendocrine, and behavioral responses to stress","volume":"697","author":"Gray","year":"1993","journal-title":"Ann. NY. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib27","first-page":"1","article-title":"Corticotropin-releasing factor and noradrenergic signaling exert reciprocal control over startle reactivity","volume":"21","author":"Gresack","year":"2010","journal-title":"Inter. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib28","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00213-010-1998-1","article-title":"Serotonin1A receptor deletion does not interact with maternal separation-induced increases in startle reactivity and prepulse inhibition deficits","volume":"214","author":"Groenink","year":"2011","journal-title":"Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib29","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.biopsych.2007.06.002","article-title":"CRF1 not glucocorticoid receptors mediate prepulse inhibition deficits in mice overexpressing CRF","volume":"63","author":"Groenink","year":"2008","journal-title":"Biol. Psychiat"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib30","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0006-3223(98)00034-1","article-title":"Effects of experimental context and explicit threat cues on acoustic startle in Vietnam veterans with posttraumatic stress disorder","volume":"44","author":"Grillon","year":"1998","journal-title":"Biol. Psychiat"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0031-9384(72)90341-1","article-title":"Effects of prestimulation on the electromyographic response associated with the acoustic startle reaction in rats","volume":"8","author":"Hammond","year":"1972","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib32","doi-asserted-by":"crossref","first-page":"15049","DOI":"10.1073\/pnas.95.25.15049","article-title":"Elevated anxiety and antidepressant-like response in serotonin 5-HT1A receptor mutant mice","volume":"95","author":"Heisler","year":"1998","journal-title":"Proc. Nat. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib79","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s002130050654","article-title":"The behavioural effects of corticotropin-releasing factor-related peptides in rats","volume":"138","author":"Jones","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib33","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1037\/0022-006X.66.1.185","article-title":"Influence of emotional engagement and habituation on exposure therapy for PTSD","volume":"66","author":"Jaycox","year":"1998","journal-title":"J.\u00a0Consult. Clin. Psychol."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/74271","article-title":"Deletion of Crhr2 reveals an anxiolytic role of corticotropin-releasing hormone receptor-2","volume":"24","author":"Kishimoto","year":"2000","journal-title":"Nat. Gen."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0166-4328(97)02296-1","article-title":"The acoustic startle response in rats \u2013 circuits mediating evocation, inhibition and potentiation","volume":"89","author":"Koch","year":"1997","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00213-006-0566-1","article-title":"The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats","volume":"189","author":"Krebs-Thomson","year":"2006","journal-title":"Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib37","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.biopsych.2006.05.022","article-title":"Reduced serotonin-1A receptor binding in social anxiety disorder","volume":"61","author":"Lanzenberger","year":"2007","journal-title":"Biol. Psychiat"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib38","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/BF02244567","article-title":"Effects of 5-HT-1A receptor agonists on CRF-induced behavior","volume":"104","author":"Lazosky","year":"1991","journal-title":"Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib39","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1523\/JNEUROSCI.12-06-02303.1992","article-title":"Corticotropin-releasing factor: long-lasting facilitation of the acoustic startle reflex","volume":"12","author":"Liang","year":"1992","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib40","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1523\/JNEUROSCI.12-06-02313.1992","article-title":"Lesions of the central nucleus of the amygdala, but not the paraventricular nucleus of the hypothalamus, block the excitatory effect of corticotropin-releasing factor on the acoustic startle reflex","volume":"12","author":"Liang","year":"1992","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib41","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1073\/pnas.92.3.836","article-title":"Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain","volume":"92","author":"Lovenberg","year":"1995","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/da.10026","article-title":"Prepulse inhibition deficits in patients with panic disorder","volume":"15","author":"Ludewig","year":"2002","journal-title":"Dep. Anxiety"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejphar.2007.09.024","article-title":"Corticotropin-releasing factor 1 and 2 receptors in the dorsal raphe differentially affect serotonin release in the nucleus accumbens","volume":"578","author":"Lukkes","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib44","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nn.2529","article-title":"CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling","volume":"13","author":"Magalhaes","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib45","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.brainresbull.2008.02.011","article-title":"Restraint stress increases serotonin release in the central nucleus of the amygdala via activation of corticotropin-releasing factor receptors","volume":"76","author":"Mo","year":"2008","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib46","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/nn1123","article-title":"Limbic corticotropin-releasing hormone 1 mediates anxiety-related behavior and hormonal adaptation to stress","volume":"6","author":"Muller","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib47","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1192\/bjp.bp.107.041186","article-title":"Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study","volume":"193","author":"Nash","year":"2008","journal-title":"Brit. J. Psychiat"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib48","doi-asserted-by":"crossref","first-page":"10734","DOI":"10.1073\/pnas.95.18.10734","article-title":"Increased anxiety in mice lacking the serotonin1A receptor","volume":"95","author":"Parks","year":"1998","journal-title":"Proc. Nat. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib80","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib49","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00213-005-2193-7","article-title":"Yohimbine disrupts prepulse inhibition in rats via action at 5-HT1A receptors, not \u03b12-adrenoceptors","volume":"180","author":"Powell","year":"2005","journal-title":"Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib50","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0893-133X(97)00197-8","article-title":"Effects of corticotropin-releasing factor on brain serotonergic activity","volume":"18","author":"Price","year":"1998","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib51","doi-asserted-by":"crossref","first-page":"14476","DOI":"10.1073\/pnas.95.24.14476","article-title":"Serotonin receptor 1A knockout: an animal model of anxiety-related disorder","volume":"95","author":"Ramboz","year":"1998","journal-title":"Proc. Nat. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/(SICI)1098-2396(199710)27:2<145::AID-SYN5>3.0.CO;2-E","article-title":"Serotonin-1A antagonists attenuate the effects of nicotine withdrawal on the auditory startle response","volume":"27","author":"Rasmussen","year":"1997","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib53","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0022-3565(25)10375-3","article-title":"5-Hydroxytryptamine1a receptor agonists block prepulse inhibition of acoustic startle reflex","volume":"263","author":"Rigdon","year":"1992","journal-title":"J.\u00a0Pharmacol. Exper. Ther."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib54","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s00213-003-1535-6","article-title":"Role of corticotropin-releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice","volume":"170","author":"Risbrough","year":"2003","journal-title":"Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib55","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.yhbeh.2006.06.019","article-title":"Role of corticotropin releasing factor in anxiety disorders: a translational research perspective","volume":"50","author":"Risbrough","year":"2006","journal-title":"Horm. Behav."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib56","doi-asserted-by":"crossref","first-page":"6545","DOI":"10.1523\/JNEUROSCI.5760-03.2004","article-title":"Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior","volume":"24","author":"Risbrough","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib57","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s00213-006-0362-y","article-title":"Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes","volume":"186","author":"Sahuque","year":"2006","journal-title":"Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib58","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0006-3223(03)00571-7","article-title":"Corticotropin-releasing factor in posttraumatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD, and healthy control subjects","volume":"54","author":"Sauter","year":"2003","journal-title":"Biol. Psychiat"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib59","doi-asserted-by":"crossref","first-page":"10477","DOI":"10.1073\/pnas.93.19.10477","article-title":"CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors","volume":"93","author":"Schulz","year":"1996","journal-title":"Proc. Nat. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib60","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF02245096","article-title":"8-OH-DPAT disruption of prepulse inhibition in rats: reversal with (+) WAY 100,135 and localization of site of action","volume":"117","author":"Sipes","year":"1995","journal-title":"Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib61","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0896-6273(00)80491-2","article-title":"Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development","volume":"20","author":"Smith","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib62","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00213-001-0940-y","article-title":"Time-dependent induction of anxiogenic-like effects of central infusion of urocortin or corticotropin-releasing factor","volume":"160","author":"Spina","year":"2002","journal-title":"Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib63","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1523\/JNEUROSCI.14-05-02579.1994","article-title":"Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior","volume":"14","author":"Stenzel-Poore","year":"1994","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib64","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.neuropharm.2010.12.022","article-title":"Restraint stress-induced reduction in prepulse inhibition in Brown Norway rats: role of the CRF2 receptor","volume":"60","author":"Sutherland","year":"2011","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib65","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.pbb.2008.01.004","article-title":"The effect of corticotropin-releasing factor on prepulse inhibition is independent of serotonin in Brown Norway and Wistar-Kyoto rats","volume":"89","author":"Sutherland","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib66","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000123454","article-title":"Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study","volume":"36","author":"Swanson","year":"1983","journal-title":"Neuroendocrinol"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib67","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0893-133X(89)90033-X","article-title":"Potentiation of startle by corticotropin-releasing factor and fear are both reversed by alpha-helical CRF","volume":"2","author":"Swerdlow","year":"1989","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib68","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s002130100799","article-title":"Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges","volume":"156","author":"Swerdlow","year":"2001","journal-title":"Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib69","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0149-7634(01)00046-X","article-title":"Role of CRF1 and CRF2 receptors in fear and anxiety","volume":"25","author":"Takahashi","year":"2001","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib70","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00213-010-1799-6","article-title":"The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat","volume":"210","author":"Tejeda","year":"2010","journal-title":"Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib71","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/520","article-title":"Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1","volume":"19","author":"Timpl","year":"1998","journal-title":"Nat. Gen."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib72","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.6267699","article-title":"Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin","volume":"213","author":"Vale","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib73","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brainres.2009.09.100","article-title":"Corticotropin-releasing factor in the dorsal raphe nucleus: linking stress coping and addiction","volume":"1314","author":"Valentino","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib74","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1046\/j.1460-9568.2002.02040.x","article-title":"Effects of transgenic overproduction of CRH on anxiety-like behavior","volume":"15","author":"Van Gaalen","year":"2002","journal-title":"Eur.J. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib75","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1023\/A:1020177023209","article-title":"Fear activation and habituation patterns as early process predictors of response to prolonged exposure treatment in PTSD","volume":"15","author":"van Minnen","year":"2002","journal-title":"J.\u00a0Traum. Stress"},{"key":"10.1016\/j.neuropharm.2011.07.016_bib76","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U","article-title":"Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse","volume":"428","author":"Van Pett","year":"2000","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib77","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.pbb.2007.01.018","article-title":"Role of dopamine D1 and D2 receptors in CRF-induced disruption of sensorimotor gating","volume":"86","author":"Vinkers","year":"2007","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2011.07.016_bib78","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jchemneu.2011.05.011","article-title":"Collateralized dorsal raphe nucleus projections: a mechanism for the integration of diverse functions during stress","volume":"41","author":"Waselus","year":"2011","journal-title":"J. Chem. Neuroanat"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811002929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811002929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T04:14:58Z","timestamp":1741407298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390811002929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0028390811002929"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2011.07.016","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}